Table 1.
Demographic, clinical characteristics and treatment characteristics of survivors with or without ‘excessive mucus discharge’ after pelvic radiation therapy.
Fig 1.
Factor loadings associated with ‘excessive mucus discharge’.
The crosses illustrate the factor loadings corresponding to the three symptoms associated to ‘excessive mucus discharge’.
Fig 2.
Dose-volume histograms for the survivors with and without ‘excessive mucus discharge’.
Mean cumulative DVHs of rectum, sigmoid colon and small intestines for survivors with (black line) and without (grey line) ‘excessive mucus discharge’.
Table 2.
Mean and maximum doses in the three OARs, for patients with and without ‘excessive mucus discharge’ and correlation coefficients between mean and maximum absorbed doses.
Fig 3.
The figure illustrates the dose-response curves of mean dose to the: (a) rectum, (b) sigmoid colon and (c) small intestine using the Probit model, the Relative Seriality (RS) model, the LKB model. Panel d illustrates the mean dose to the small intestine for the Probit, Relative Seriality (RS) and LKB models.
Table 3.
The maximum likelihood estimates of the dose-volume response parameters for the three OAR using Probit, RS, LKB and EUD models and the values for the AUC (area under the ROC curve).